Actively Recruiting

Phase Not Applicable
Age: 30Years - 55Years
All Genders
Healthy Volunteers
NCT04791371

Role of Microvascular Insulin Resistance and Cardiorespiratory Fitness Diabetes

Led by University of Colorado, Denver · Updated on 2026-03-23

150

Participants Needed

2

Research Sites

243 weeks

Total Duration

On this page

Sponsors

U

University of Colorado, Denver

Lead Sponsor

U

University of Virginia

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this two-site grant proposal is to determine the role of the decreased insulin-mediated muscle perfusion found in type 2 diabetes in contributing to the development of cardiac and skeletal muscle dysfunction and subsequent functional exercise impairment. In addition, it is also our goal to determine whether exercise training attenuates insulin resistance and restores insulin-mediated perfusion to the heart and to skeletal muscle, leading to improved cardiac function and exercise performance.

CONDITIONS

Official Title

Role of Microvascular Insulin Resistance and Cardiorespiratory Fitness Diabetes

Who Can Participate

Age: 30Years - 55Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Sedentary (defined as less than 1 hour per week of physical activity)
  • Body mass index (BMI) between 25 and 40
  • Men and women with or without type 2 diabetes
  • Age between 30 and 55 years
Not Eligible

You will not qualify if you...

  • Documented cardiovascular disease
  • Uncontrolled hypertension with systolic blood pressure (SBP) > 150 or diastolic blood pressure (DBP) > 110
  • Obstructive pulmonary disease or asthma
  • Peripheral neuropathy
  • Physical impairment limiting ability to exercise
  • Taking beta blockers, calcium channel blockers, insulin, or Thiazolidinediones (TZD)
  • Current or past smoking within the last 1 year
  • Current tobacco use
  • Anemia
  • Control HbA1c > 5.7 or type 2 diabetes HbA1c > 9
  • Pregnant, nursing, or using hormonal therapy other than contraceptives
  • Peri or post-menopausal women
  • Type 1 diabetes
  • Hepatic or renal disease

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

University of Colorado

Aurora, Colorado, United States, 80045

Actively Recruiting

2

University of Virginia

Charlottesville, Virginia, United States, 22908

Actively Recruiting

Loading map...

Research Team

B

Benjamin Juckett, MS

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Role of Microvascular Insulin Resistance and Cardiorespiratory Fitness Diabetes | DecenTrialz